Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial

Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a completed Phase II study of navarixin with pembrolizumab, including its eligibility criteria, outcomes, and study documents.
    Difference
    64%
    Check dated 2026-11-07T11:44:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T12:24:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A banner announces an NIH website terminology transition, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T12:08:01.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision indicator changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T13:14:32.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:57:58.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error page, blocking access to the study record. This prevents viewing the study details, status, and related information on ClinicalTrials.gov.
    Difference
    20%
    Check dated 2026-09-19T18:11:00.000Z thumbnail image

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.